Rémy Nicolle

Remy Nicolle obtained his Ph.D. at the Institut Curie (Paris, France) studying the transcriptional dysregulations driving bladder cancer. He joined the “Carte d’Identité des Tumeurs” group in 2015, a cancer genomics program launched by the Ligue Contre le Cancer, to focus on the genomics of pancreatic cancer.

Top